IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FcγRIIb cross-linking

Journal of Clinical Investigation

Volumn 116, Issue 3, 2006, Pages 833-841

  Strait, Richard T ^a,b   Morris, Suzanne C ^b,c   Finkelman, Fred D ^b,c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIGEN; BLOCKING ANTIBODY; EPITOPE; FC RECEPTOR IIB; FC RECEPTOR III; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN RECEPTOR; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS LINKING; DRUG ACTIVITY; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL;

ANAPHYLAXIS; ANIMALS; ANTIBODIES, BLOCKING; ANTIGENS; CROSS-LINKING REAGENTS; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, IGG;

EID: 33644638676     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI25575     Document Type: Article

References (54)

1. Flicker, S., and Valenta, R. 2003. Renaissance of the blocking antibody concept in type I allergy. Int. Arch. Allergy Immunol. 132:13-24.
2. Galli, S., and Lantz, C. 1999. Allergy. In Fundamental immunology. W.E. Paul, editor. Lippincott-Raven. Philadelphia, Pennsylvania, USA. 1127-1174.
3. Daeron, M., Malbec, O., Latour, S., Arock, M., and Fridman, W.H. 1995. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J. Clin. Invest. 95:577-585.
4. Sade, K., Kivity, S., Levy, A., and Fireman, E. 2003. The effect of specific immunotherapy on T-cell receptor repertoire in patients with allergy to house-dust mite. Allergy. 58:430-434.
5. + T cells by inhibiting serum-IgE-facilitated allergen presentation. J. Immunol. 163:2944-2952.
6. Durham, S.R., and Till, S.J. 1998. Immunologic changes associated with allergen immunotherapy. J. Allergy Clin. Immunol. 102:157-164.
7. + T cells by grass pollen immunotherapy. J. Allergy Clin. Immunol. 111:1255-1261.
8. Golden, D.B., et al. 1982. Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy. J. Allergy Clin. Immunol. 69:489-493.
9. Urbanek, R., Krauss, U., Ziupa, J., and Smedegard, G. 1983. Venom-specific IgE and IgG antibodies as a measure of the degree of protection in insect-sting-sensitive patients. Clin. Allergy. 13:229-234.
10. Kemeny, D.M., et al. 1989. IgG and IgE antibodies after immunotherapy with bee and wasp venom. Int. Arch. Allergy Appl. Immunol. 88:247-249.
11. Golden, D.B., et al. 1992. Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy. J. Allergy Clin. Immunol. 90:386-393.
12. Ewan, P.W., Deighton, J., Wilson, A.B., and Lachmann, P.J. 1993. Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings. Clin. Exp. Allergy. 23:647-660.
13. Garcia, B.E., Sanz, M.L., Gato, J.J., Fernandez, J., and Oehling, A. 1993. IgG4 blocking effect on the release of antigen-specific histamine. J. Investig. Allergol. Clin. Immunol. 3:26-33.
14. Nouri-Aria, K.T., et al. 2004. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J. Immunol. 172:3252-3259.
15. Finkelman, F.D., et al. 1982. Polyclonal activation of the murine immune system by an antibody to IgD. II. Generation of polyclonal antibody production and cells with surface IgG. J. Immunol. 129:638-646.
16. Champion, B.R., Buckham, S., Page, K., Obray, H., and Zanders, E.D. 1991. Secondary immunoglobulin responses of BALB/c mice previously stimulated with goat anti-mouse IgD. Immunology. 72:336-343.
17. Finkelman, F.D., Snapper, C.M., Mountz, J.D., and Katona, I.M. 1987. Polyclonal activation of the murine immune system by a goat antibody to mouse IgD. IX. Induction of a polyclonal IgE response. J. Immunol. 138:2826-2830.
18. Svetic, A., et al. 1991. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J. Immunol. 147:2391-2397.
19. Mountz, J.D., Smith, J., Snapper, C.M., Mushinski, J.F., and Finkelman, F.D. 1987. Polyclonal activation of the murine immune system by an antibody to IgD. VIII. Stimulation of IgD secretion. J. Immunol. 139:2172-2178.
20. Strait, R.T., Morris, S.C., Yang, M., Qu, X.W., and Finkelman, F.D. 2002. Pathways of anaphylaxis in the mouse. J. Allergy Clin. Immunol. 109:658-668.
21. Lees, A., et al. 1990. Rapid stimulation of large specific antibody responses with conjugates of antigen and anti-IgD antibody. J. Immunol. 145:3594-3600.
22. Singh, B., and de la Concha-Bermejillo, A. 1998. Gadolinium chloride removes pulmonary intravascular macrophages and curtails the degree of ovine lentivirus-induced lymphoid interstitial pneumonia. Int. J. Exp. Pathol. 79:151-162.
23. Rai, R.M., Zhang, J.X., Clemens, M.G., and Diehl, A.M. 1996. Gadolinium chloride alters the acinar distribution of phagocytosis and balance between pro- and anti-inflammatory cytokines. Shock. 6:243-247.
24. Lazar, G., Jr., et al. 1994. Inhibition of anaphylactic shock by gadolinium chloride-induced Kupffer cell blockade. Agents Actions. 41:C97-C98.
25. Khodoun, M.V., Orekhova, T., Potter, C., Morris, S., and Finkelman, F.D. 2004. Basophils initiate IL-4 production during a memory T-dependent response. J. Exp. Med. 200:857-870.
26. Ujike, A., et al. 1999. Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J. Exp. Med. 189:1573-1579.
27. Takai, T., Ono, M., Hikida, M., Ohmori, H., and Ravetch, J.V. 1996. Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature. 379:346-349.
28. Zhang, K., et al. 2004. Inhibition of allergen-specific IgE reactivity by a human Ig Fcγ-Fcε bifunctional fusion protein. J. Allergy Clin. Immunol. 114:321-327.
29. Saxon, A., Zhu, D., Zhang, K., Allen, L.C., and Kepley, C.L. 2004. Genetically engineered negative signaling molecules in the immunomodulation of allergic diseases. Curr. Opin. Allergy Clin. Immunol. 4:563-568.
30. Su, K., et al. 2004. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIb alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function. J. Immunol. 172:7192-7199.
31. Li, X., et al. 2003. A novel polymorphism in the FcγRIIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum. 48:3242-3252.
32. Finkelman, F.D., Rothenberg, M.E., Brandt, E.B., Morris, S.C., and Strait, R.T. 2005. Molecular mechanisms of anaphylaxis: lessons from studies with murine models [review]. J. Allergy Clin. Immunol. 115:449-457; quiz 458.
33. Galli, S.J. 2005. Pathogenesis and management of anaphylaxis: current status and future challenges. J. Allergy Clin. Immunol. 115:571-574.
34. Poole, J.A., Matangkasombut, P., and Rosenwasser, L.J. 2005. Targeting the IgE molecule in allergic and asthmatic diseases: review of the IgE molecule and clinical efficacy [review]. J. Allergy Clin. Immunol. 115(Suppl. 3):S376-S385.
35. Zhu, D., et al. 2005. A chimeric human-cat fusion protein blocks cat-induced allergy. Nat. Med. 11:446-449.
36. Ali, F.R., Kay, A.B., and Larche, M. 2002. The potential of peptide immunotherapy in allergy and asthma. Curr. Allergy Asthma Rep. 2:151-158.
37. Fellrath, J.M., et al. 2003. Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial. J. Allergy Clin. Immunol. 111:854-861.
38. Kemeny, D.M., MacKenzie-Mills, M., Harries, M.G., Youlten, L.J., and Lessof, M.H. 1983. Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens. J. Allergy Clin. Immunol. 72:376-385.
39. Svenson, M., et al. 2003. Vaccination for birch pollen allergy. Induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1. Mol. Immunol. 39:603-612.
40. Tazaki, T., et al. 2004. Allergen rush immunotherapy increases interleukin (IL)-12 production and IL-12Rβ2 chain expression in patients with allergic asthma. Cell. Immunol. 228:20-26.
41. Ippoliti, F., et al. 2003. Immunomodulation during sublingual therapy in allergic children. Pediatr. Allergy Immunol. 14:216-221.
42. Wachholz, P.A., et al. 2002. Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios. Immunology. 105:56-62.
43. Kitamura, Y., Go, S., and Hatanaka, K. 1978. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood. 52:447-452.
44. Oettgen, H.C., et al. 1994. Active anaphylaxis in IgE-deficient mice. Nature. 370:367-370.
45. Finkelman, F.D., Scher, I., Mond, J.J., Kung, J.T., and Metcalf, E.S. 1982. Polyclonal activation of the murine immune system by an antibody to IgD. I. Increase in cell size and DNA synthesis. J. Immunol. 129:629-637.
46. Unkeless, J.C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580-596.
47. Baniyash, M., and Eshhar, Z. 1984. Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE. Eur. J. Immunol. 14:799-807.
48. Rudolph, A.K., Burrows, P.D., and Wabl, M.R. 1981. Thirteen hybridomas secreting hapten-specific immunoglobulin E from mice with Iga or Igb heavy chain haplotype. Eur. J. Immunol. 11:527-529.
49. Finkelman, F.D., Kessler, S.W., Mushinski, J.F., and Potter, M. 1981. IgD-secreting murine plasmacytomas: identification and partial characterization of two IgD myeloma proteins. J. Immunol. 126:680-687.
50. Finkelman, F.D., et al. 1993. Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J. Immunol. 151:1235-1244.
51. Finkelman, F.D., and Morris, S.C. 1999. Development of an assay to measure in vivo cytokine production in the mouse. Int. Immunol. 11:1811-1818.
52. Strait, R.T., Morris, S.C., Smiley, K., Urban, J.F., Jr., and Finkelman, F.D. 2003. IL-4 exacerbates anaphylaxis. J. Immunol. 170:3835-3842.
53. Mizgerd, J.P., Molina, R.M., Stearns, R.C., Brain, J.D., and Warner, A.E. 1996. Gadolinium induces macrophage apoptosis. J. Leukoc. Biol. 59:189-195.
54. Mischell, B., and Shiigi, S. 1980. Selected methods in cellular immunology. Freeman. San Francisco, California, USA. 346-349.